These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2481407

  • 1. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
    Reidelberger RD, O'Rourke MF.
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
    [Abstract] [Full Text] [Related]

  • 2. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
    O'Rourke MF, Reidelberger RD, Solomon TE.
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
    [Abstract] [Full Text] [Related]

  • 3. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J, Konturek PK, Majka J, Kwiecien N, Konturek SJ.
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS, Liang JP, Owyang C.
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
    Akiyama T, Tachibana I, Otsuki M.
    Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RS, Clineschmidt BV.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA, Adrian TE, Bilchik AJ, Modlin IM.
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of atropine on pancreatic response to bethanechol, cholecystokinin, and food intake in rats.
    O'Rourke MF, Reidelberger RD, Solomon TE.
    Am J Physiol; 1991 Nov; 261(5 Pt 1):G735-41. PubMed ID: 1683164
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.